SCHEMBL6979739

SCHEMBL6979739

CCCNC(=O)c1ccc2c(c1)C(=C(Nc1ccccc1)c1ccccc1)C(=O)N2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
PAK4 O96013 5/20 0.43
KMT2A Q03164 1/20 0.42
PDK2 Q15119 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GRK5 P34947 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
PDPK1 O15530 1/20 0.40
POLB P06746 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979734 1.00 L3MBTL1 (0.45) L3MBTL1PAK4KMT2APDK2ALDH1A1
SCHEMBL8192683 0.94 SMN1; SMN2 (0.48) PAK4ALDH1A1GAAPOLBHTT
SCHEMBL6977915 0.93 PAK4 (0.42) L3MBTL1PAK4KMT2APDK2GRK5
SCHEMBL7987909 0.93 PAK4 (0.42) L3MBTL1PAK4KMT2APDK2GRK5
SCHEMBL2568750 0.92 L3MBTL1 (0.45) L3MBTL1KMT2APDK2ALDH1A1KDM4E
SCHEMBL6985636 0.90 ROCK2 (0.42) L3MBTL1PAK4GRK5CYP3A4PDPK1
SCHEMBL6985634 0.90 ROCK2 (0.42) L3MBTL1PAK4GRK5CYP3A4PDPK1
SCHEMBL6980866 0.89 SIGMAR1 (0.45) KMT2AKDM4EGRK5GAANAMPT
SCHEMBL6980870 0.89 SIGMAR1 (0.45) KMT2AKDM4EGRK5GAANAMPT
SCHEMBL6986773 0.88 LMNA (0.42) L3MBTL1PAK4GRK5CYP3A4PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed